28 assets in Chemotherapy-Induced Neuropathy

Therapeutic assets addressing Chemotherapy-Induced Neuropathy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Pregabalin Chemotherapy-Induced Neuropathy	University of Rochester	P4	BB (71)
Lidocaine Chemotherapy-Induced Neuropathy	Hospital Ambroise Paré Paris	P2	BB (64)
Omeprazole Chemotherapy-Induced Neuropathy	Aya Mohamed Sadek Elsaid	P3	BB (64)
Docetaxel Chemotherapy-Induced Neuropathy	Mansoura University	P2	B (57)
(E)-3-(2-((5-(3-(Phenylsulfonamido)Phenyl)Pent-4-En-1-Yl)Oxy)Phenyl)Propanoic Acid Chemotherapy-Induced Neuropathy	Ono Pharmaceutical Co., Ltd.	P2	B (57)
Losartan Chemotherapy-Induced Neuropathy	Future University in Egypt	P2	B (57)
Oxygen Chemotherapy-Induced Neuropathy	Bernardino Clavo, MD, PhD	P2/3	B (57)
Pentoxifylline Chemotherapy-Induced Neuropathy	Mansoura University	P2	B (57)
Triatomic Oxygen Chemotherapy-Induced Neuropathy	Bernardino Clavo, MD, PhD	P2/3	B (57)
Duloxetine Chemotherapy-Induced Neuropathy	University of Rochester	P2	CCC (53)
Halneuron Chemotherapy-Induced Neuropathy	Dogwood Therapeutics Inc.	P2	CCC (53)
Hydroxychloroquine Chemotherapy-Induced Neuropathy	University of Arizona	P2	CCC (53)
Palmidrol Chemotherapy-Induced Neuropathy	Academic and Community Cancer Research United	P2	CCC (53)
Tarichatoxin Chemotherapy-Induced Neuropathy	Wex Pharmaceuticals Inc.	P2	CCC (53)
Vmd-3866 Chemotherapy-Induced Neuropathy	VM Therapeutics LLC	P2	CCC (53)
Trimetazidine Chemotherapy-Induced Neuropathy	Minia University	P1/2	CCC (52)
Monosialotetrahexosylganglioside Chemotherapy-Induced Neuropathy	Alliance for Clinical Trials in Oncology	P2	CCC (48)
Thrombomodulin Alfa (Genetical Recombination) Chemotherapy-Induced Neuropathy	Veloxis Pharmaceuticals	P1	CC (43)
Delta-8-Tetrahydrocannabinol Chemotherapy-Induced Neuropathy	City of Hope Medical Center	Early P1	C (39)
Acetylcysteine Chemotherapy-Induced Neuropathy	Department of Medical Services Ministry of Public Health of Thailand	N/A	D (30)
Capsaicin Chemotherapy-Induced Neuropathy	Hospital Ambroise Paré Paris	N/A	D (30)
Trans-Cinnamaldehyde Chemotherapy-Induced Neuropathy	Universitaire Ziekenhuizen KU Leuven	N/A	D (30)
gm1 Chemotherapy-Induced Neuropathy	Qilu Pharmaceutical Co., Ltd.	P3	NR ()
Mirogabalin Chemotherapy-Induced Neuropathy	Pusan National University Yangsan Hospital	N/A	NR ()
Monosialotetrahexose Ganglioside Sodium Chemotherapy-Induced Neuropathy	Qilu Pharmaceutical Co., Ltd.	P2/3	NR ()